Kyongbo Pharmaceutical Co Ltd (214390) — Tangible Net Worth Ratio
Kyongbo Pharmaceutical Co Ltd (214390) has a Tangible Net Worth Ratio of 96.6% as of June 2026. This metric is calculated by deducting intangible assets (₩4.98 Billion) from net assets (₩146.99 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset growth rate of Kyongbo Pharmaceutical Co Ltd to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Kyongbo Pharmaceutical Co Ltd Tangible Net Worth Ratio (2014–2025)
This chart shows how Kyongbo Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 12 annual periods from 2014 to 2025. As of June 2026, the ratio stands at 96.6%, reflecting net assets of ₩146.99 Billion with intangible assets of ₩4.98 Billion KRW. For live market cap and overall valuation, see market cap of Kyongbo Pharmaceutical Co Ltd.
Annual Tangible Net Worth Ratio for Kyongbo Pharmaceutical Co Ltd (2014–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Kyongbo Pharmaceutical Co Ltd from 2014 to 2025, covering 12 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Kyongbo Pharmaceutical Co Ltd (214390) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (KRW) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 97.3% | ₩145.74 Billion | ₩3.88 Billion | ₩319.54 Billion | ▲ +0.1 pp |
| 2024 | 97.3% | ₩146.15 Billion | ₩4.01 Billion | ₩283.89 Billion | ▼ -0.2 pp |
| 2023 | 97.5% | ₩144.38 Billion | ₩3.64 Billion | ₩266.31 Billion | ▼ -0.3 pp |
| 2022 | 97.8% | ₩143.70 Billion | ₩3.22 Billion | ₩240.54 Billion | ▲ +0.1 pp |
| 2021 | 97.7% | ₩145.70 Billion | ₩3.35 Billion | ₩236.98 Billion | ▼ -0.3 pp |
| 2020 | 98.0% | ₩156.06 Billion | ₩3.09 Billion | ₩253.24 Billion | ▲ +0.4 pp |
| 2019 | 97.7% | ₩149.16 Billion | ₩3.48 Billion | ₩237.82 Billion | ▼ -0.7 pp |
| 2018 | 98.3% | ₩149.01 Billion | ₩2.50 Billion | ₩221.62 Billion | ▲ +0.1 pp |
| 2017 | 98.2% | ₩141.51 Billion | ₩2.58 Billion | ₩204.87 Billion | ▲ +0.8 pp |
| 2016 | 97.4% | ₩129.40 Billion | ₩3.35 Billion | ₩203.74 Billion | ▼ -1.3 pp |
| 2015 | 98.7% | ₩122.82 Billion | ₩1.64 Billion | ₩195.49 Billion | ▲ +1.7 pp |
| 2014 | 97.0% | ₩68.33 Billion | ₩2.07 Billion | ₩168.03 Billion | — |